DLL4 and neoplasm: For that we increased the number of circulating BM-VPC by administering mouse BM-VPC derived from Dll4GOF mice with induced Dll4 over-expression (mDll4GOF BM-VPC) or normal Dll4 expression (WT BM-VPC) after tumor establishment during a restricted period of time.